InvestorsHub Logo
Post# of 253269
Next 10
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

Re: DewDiligence post# 42490

Monday, 02/26/2007 5:18:43 PM

Monday, February 26, 2007 5:18:43 PM

Post# of 253269
re Threshold:

That's a tough result. It would be interesting to know the percentage of patients in each arm who received Tarceva on top of Gemzar. It also would be interesting to see if there were any QOL aspects of the trial in the SAP, and how they played out in each arm.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.